NCT05331716View on ClinicalTrials.gov

Modification of the Local Abnormal Ventricular Activity Only

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Ventricular Tachycardia
Interventions
PROCEDURE

Cardiac ablation therapy

In a subset of patients with known therapy refractory arrhythmia sole LAVA modification is fashioned

Trial Locations (1)

84036

Krankenhaus Landshut Achdorf, Landshut

All Listed Sponsors
collaborator

Krankenhaus Landshut Achdorf

UNKNOWN

lead

University of Kiel

OTHER

NCT05331716 - Modification of the Local Abnormal Ventricular Activity Only | Biotech Hunter | Biotech Hunter